Intron fusion proteins, and methods of identifying and using same

Details for Australian Patent Application No. 2004265226 (hide)

Owner Receptor Biologix, Inc.

Inventors Clinton, Gail M.; Shepard, H. Michael; Jin, Pei; Lackey, David B.

Agent Spruson & Ferguson

Pub. Number AU-A-2004265226

PCT Pub. Number WO2005/016966

Priority 60/471,141 16.05.03 US

Filing date 14 May 2004

Wipo publication date 24 February 2005

International Classifications

C07K 014/71 Peptides having more than 20 amino acids

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2005/016966 Priority application(s): WO2005/016966

28 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265232-Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens

2004265213-Strength-enhanced, lightweight lignocellulosic composite board materials and methods for their manufacture